• Altman, D.G., Schulz, K.F., Moher, D., Egger, M., Davidoff, F., Elbourne, D., Gotzsche, P.C. & Lang, T. (2001) The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Annals of Internal Medicine, 134, 663694.
  • Baglin, T. (2007) Unprovoked deep vein thrombosis should be treated with long-term anticoagulation: no. Journal of Thrombosis and Haemostasis, 5, 23362339.
  • Baglin, T. (2008) Venous thromboembolism in hospitalised patients: a public health crisis? British Journal of Haematology, 141, 764770.
  • Bloemenkamp, K.W., Rosendaal, F.R., Helmerhorst, F.M. & Vandenbroucke, J.P. (2000) Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects. Archives of Internal Medicine, 160, 4952.
  • Calman, K.C. & Royston, G.H. (1997) Risk language and dialects. British Medical Journal, 315, 939942.
  • Devereaux, P.J., Anderson, D.R., Gardner, M.J., Putnam, W., Flowerdew, G.J., Brownell, B.F., Nagpal, S. & Cox, J.L. (2001) Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. British Medical Journal, 323, 12181222.
  • Von Elm, E., Altman, D.G., Egger, M., Pocock, S.J., Gotzsche, P.C. & Vandenbroucke, J.P. (2007) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med, 4, e296.
  • Elwyn, G., Edwards, A., Hood, K., Robling, M., Atwell, C., Russell, I., Wensing, M. & Grol, R. (2004) Achieving involvement: process outcomes from a cluster randomized trial of shared decision making skill development and use of risk communication aids in general practice. Family Practitioner, 21, 337346.
  • Hutton, J.L. (2009) Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials. British Journal of Haematology, doi: DOI: 10.1111/j.1365-2141.2009.07707.x
  • Kearon, C. (2007) Indefinite anticoagulation after a first episode of unprovoked venous thromboembolism: yes. Journal of Thrombosis and Haemostasis, 5, 23302335.
  • Locadia, M., Bossuyt, P.M., Stalmeier, P.F., Sprangers, M.A., Van Dongen, C.J., Middeldorp, S., Bank, I., Van Der Meer, J., Hamulyak, K. & Prins, M.H. (2004) Treatment of venous thromboembolism with vitamin k antagonists: patients’ health state valuations and treatment preferences. Thrombosis and Haemostasis, 92, 13361341.
  • Protheroe, J., Fahey, T., Montgomery, A.A. & Peters, T.J. (2000) The impact of patients’ preferences on the treatment of atrial fibrillation: observational study of patient based decision analysis. British Medical Journal, 320, 13801384.
  • Saukko, P.M., Ellard, S., Richards, S.H., Shepherd, M.H. & Campbell, J.L. (2007) Patients’ understanding of genetic susceptibility testing in mainstream medicine: qualitative study on thrombophilia. BioMed Central Health Services Research, 7, 82.
  • Smeeth, L. (2000) Commentary: patients, preferences, and evidence. British Medical Journal, 320, 1384.
  • Thomson, R., Robinson, A., Greenaway, J. & Lowe, P. (2002) Development and description of a decision analysis based decision support tool for stroke prevention in atrial fibrillation. Quality and Safety in Health Care, 11, 2531.
  • Thomson, R., Edwards, A. & Grey, J. (2005) Risk communication in the clinical consultation. Clinical Medicine, 5, 465469.
  • Varga, E. (2007) Inherited thrombophilia: key points for genetic counseling. Journal of Genetic Counseling, 16, 261277.